Trying to understand when we're likely to have Cohort 3's read out... Leslie's confirmed to me that this will be after "the 3rd patient is past 28 days." So, this must be any day now given the timing since 7 April?
Assuming all's good with the highest dose, I understand that a further 7 patients will then expand this to a total of 10 patients receiving monoclonal treatment. Then, given that the trial's estimated enrolment is 22 patients, this must mean that a further 6 patients will receive a combination of dose and SOC treatment.
Excerpt from the clinicaltrials.gov website, below.
DYOR, GLTAH
Ann: Final Highest Dose in Phase 1 Clinical Trial of PD-VAXX, page-226
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.003(6.25%) |
Mkt cap ! $379.2M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.5¢ | 4.8¢ | $4.098M | 80.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1984777 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 450000 | 3 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |